PORT WASHINGTON, N.Y.--(BUSINESS WIRE)-- Pall’s (NYSE:PLL) 2011-2012 Laboratory Filtration, Separation and Detection Products Catalog provides a convenient, all-in-one guide to the company’s line of laboratory-scale products. Critical laboratory applications showcased in the catalog include protein and DNA purification, detection and screening, laboratory bioprocessing, HPLC and chromatography sample prep, microbiology quality control, and environmental water and air. Detailed application and product selector guides, performance data, and ordering information make this catalog an important tool for every lab.
Catalog content is available at www.pall.com/lab where you’ll find online data sheets and product ordering information. For a printed copy, contact your local Pall office.
Product selection is easy with this 305-page catalog. Innovative new products and long-time favorites come together to support a wide range of applications and processing volume requirements. Highlights include scalable chromatography, tangential flow filtration, and sterile filtration products; sample prep products for pharmaceutical QC; and an expanded line of filter plates and centrifugal devices for molecular biology research.
Pall offers the widest selection of membranes with the broadest range of performance characteristics available anywhere. The Company’s technical support team is available to help customers worldwide realize the full potential of their applications. For more information about Pall laboratory products, contact Pall’s Technical Service Department: 600 South Wagner Road, Ann Arbor, Michigan, 48103, or call 800.521.1520 (USA and Canada) or (+)800.PALL.LIFE (outside USA and Canada). Visit Pall Life Sciences on the Internet at http://www.pall.com/lab or e-mail us at LabSupport@pall.com.
Pall Life Sciences
Pall Life Sciences provides cutting-edge products and services to meet the demanding needs of customers discovering, developing and producing biotech drugs, vaccines and classic pharmaceuticals. Pall technologies are also used to collect and process blood components and help protect patients from hospital-acquired infections. The company’s membranes and membrane devices optimize detection and sample preparation in the drug research, clinical diagnostics, genomics, and proteomics markets. Pall is a leading provider of separation systems and single-use filtration and purification technologies to pharmaceutical and biotechnology companies to support faster development of new drugs and vaccines that are safer and require less energy and water to produce.
About Pall Corporation
Pall Corporation (NYSE: PLL) is a filtration, separation and purification leader providing solutions to meet the critical fluid management needs of customers across the broad spectrum of life sciences and industry. Pall works with customers to advance health, safety and environmentally responsible technologies. The Company’s engineered products enable process and product innovation and minimize emissions and waste. Pall Corporation, with total revenues of $2.4 billion for fiscal 2010, is an S&P 500 company with more than 10,000 employees serving customers worldwide. To see how Pall is helping enable a greener, safer, more sustainable future, visit www.pall.com/green.
Note to Editors: A high-resolution photograph of the cover of the 2011-2012 Laboratory Filtration, Separation and Detection Catalog is available for download at www.pall.com/news
Photos/Multimedia Gallery Available: http://www.businesswire.com/cgi-bin/mmg.cgi?eid=6654161&lang=en
Contacts
Pall Corporation Melinda Yaklin Director, Marketing Communications-Biopharm Telephone: 734-913-6435 E-mail: melinda_yaklin@pall.com
